Improve walking confidence through imagery
- Trial ID
- NCT07193355
- Official Title
- Effects of Motor Imagery Training on Kinesiophobia, Gait, and Balance in Parkinson's Disease Patients
- Goal
- Improve walking confidence through imagery
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Kahramanmaras Sutcu Imam University
- Study Type
- INTERVENTIONAL
- Enrollment
- 50 participants
- Conditions
- PARKINSON DISEASE (Disorder), Mental Imagery, Gait Balance
- Interventions
- Mental Imagery Application Protocol
Plain-Language Summary
The goal is to reduce fear of movement, called kinesiophobia, and to improve walking and balance for people with Parkinson's who feel unsteady or hesitant to move. The approach uses a guided mental imagery protocol, where you rehearse walking, turning, and balance tasks in your mind to activate the same motor brain circuits as real movement, helping retrain patterns and build confidence; because it is non-drug, it can be done alongside medications like levodopa without interfering with them. Looking for adults 40 to 75 with idiopathic Parkinson's at Modified Hoehn and Yahr stage 4 or lower, who meet cognitive screening (MMSE ≥22 with formal training, or ≥18 without), have no other neurological or systemic disease, and no upper extremity contractures; people with treated psychiatric illness, on neuroleptics or antidepressants, or with certain orthopedic or rheumatologic conditions are excluded. Enrollment is 50 participants, starting July 2025.
Locations
- Kahramanmaraş Sütçü imam University, Kahramanmaraş, Onikişubat, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Mental Imagery Application Protocol. The goal is to reduce fear of movement, called kinesiophobia, and to improve walking and balance for people with Parkinson's who feel unsteady or hesitant to move. The approach uses a guided mental imagery protocol, where you rehearse walking, turning, and balance tasks in your mind to activate the same motor brain circuits as real movement, helping retrain patterns and build confidence; because it is non-drug, it can be done alongside medications like levodopa without interfering with them. Looking for adults 40 to 75 with idiopathic Parkinson's at Modified Hoehn and Yahr stage 4 or lower, who meet cognitive screening (MMSE ≥22 with formal training, or ≥18 without), have no other neurological or systemic disease, and no upper extremity contractures; people with treated psychiatric illness, on neuroleptics or antidepressants, or with certain orthopedic or rheumatologic conditions are excluded. Enrollment is 50 participants, starting July 2025.
- Who can participate?
- Participants must be between 40 Years and 75 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year.